IgG4 Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes

Human Antibodies

Volumn 13, Issue 3, 2004, Pages 91-96

  Chappel, Jonathan A ^a   Hollingdale, Michael R ^b,c   Kang, Angray S ^a,d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d AVANIR PHARMACEUTICALS   (United States)

Author keywords

human monoclonal antibodies; Plasmodium falciparum; sporozoite

Indexed keywords

IMMUNOGLOBULIN G4; MONOCLONAL ANTIBODY;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE;

EID: 12844279328     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2004-13305     Document Type: Article

References (30)

1. J.G. Breman, A. Egan and G.T. Keusch, The intolerable burden of malaria: a new look at the numbers, Am J Trop Med Hyg 64(1-2) (2001), iv-vii.
2. J. Sachs and P. Malaney, The economic and social burden of malaria, Nature 415 (2002), 680-685.
3. U. D'Alessandro, A. Leach, C.J. Drakeley, S. Bennett, B.O. Olaleye, G.W. Fegan, M. Jawara, P. Langerock, M.O. George and G.A. Targett et al., Efficacy trial of malaria vaccine SPf66 in Gambian infants, Lancet 346(8973) (1995), 462-467.
4. D. Baudon, Malaria and travelers-practical aspects, Trop Med Parasitol 44(3) (1993), 246-249.
5. H. Mulligan, P. Russell and B. Mohan, Active immunization of fowls against Plasmodium gallinaceum by injection of homologous sporozoite, J Malaria Institue India 4 (1941), 25-34.
6. R. Nussenzweig, J. Vanderberg and H. Most, Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity, Mil Med 134(10) (1969), 1176-1182.
7. P. Potocnjak, N. Yoshida, R.S. Nussenzweig and V. Nussenzweig, Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection, J Exp Med 151(6) (1980), 1504-1513.
8. J.B. Dame, J.L. Williams, T.F. McCutchan, J.L. Weber, R.A. Wirtz, W.T. Hockmeyer, W.L. Maloy, J.D. Haynes, I. Schneider and D. Roberts et al., Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum, Science 225(4662) (1984), 593-599.
9. H.J. Dyson, A.C. Satterthwait, R.A. Lerner and P.E. Wright, Conformational preferences of synthetic peptides derived from the immunodominant site of the circumsporozoite protein of Plasmodium falciparum by 1H NMR, Biochemistry 29(34) (1990), 7828-7837.
10. F. Zavala, A. Masuda, P.M. Graves, V. Nussenzweig and R.S. Nussenzweig, Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites, J Immunol 135(4) (1985), 2790-2793.
11. D.F. Clyde, V.C. McCarthy, R.M. Miller and R.B. Hornick, Specificity of protection of man immunized against sporozoite-induced falciparum malaria, Am J Med Sci 266(6) (1973), 398-403.
12. W. Hockmeyer and W. Ballou, in: Progress in Allergy, P. Perlmann and H. Wigzell, eds, Karger: Basel, 1988, pp. 1-14.
13. S.L. Hoffman, L.M. Goh, T.C. Luke, I. Schneider, T.P. Le, D.L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, D.M. Gordon, J.A. Stoute, L.W. Church, M. Sedegah, D.G. Heppner, W.R. Ballou and T.L. Richie, Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites, J Infect Dis 185(8) (2002), 1155-1164.
14. T.C. Luke and S.L. Hoffman, Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine, J Exp Biol 206(21) (2003), 3803-3808.
15. J.E. Egan, S.L. Hoffman, J.D. Haynes, J.C. Sadoff, I. Schneider, G.E. Grau, M.R. Hollingdale, W.R. Ballou and D.M. Gordon, Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites, Am J Trop Med Hyg 49(2) (1993), 166-173.
16. R. Edelman, S.L. Hoffman, J.R. Davis, M. Beier, M.B. Sztein, G. Losonsky, D.A. Herrigton, H.A. Eddy, M.R. Hollingdale and D.M. Gordon et al., Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites, J Infect Dis 168(4) (1993), 1066-1070.
17. M. Brunswick, C.H. June, F.D. Finkelman, H.M. Dintzis, J.K. Inman and J.J. Mond, Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation, Proc Natl Acad Sci USA 86(17) (1989), 6724-6728.
18. J.A. Chappel, W.O. Rogers, S.L. Hoffman and A.S. Kang, Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor, Malar J 3(1) (2004), 28.
19. F. Zavala, J.P. Tam, M.R. Hollingdale, A.M. Cochrane, I. Quakyi, R.S. Nussenzweig and V. Nussenzweig, Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria, Science 228(4706) (1985), 1436-1440.
20. L region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum, Eur J Immunol 20(12) (1990), 2757-2761.
21. H.M. Etlinger and A. Trzeciak, Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody, Philos Trans R Soc Lond B Biol Sci 340(1291) (1993), 69-72.
22. T. Dreier, H.N. Lode, R. Xiang, C.S. Dolman, R.A. Reisfeld and A.S. Kang, Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities, Bioconjug Chem 9(4) (1998), 482-489.
23. M.R. Hollingdale, E.H. Nardin, S. Tharavanij, A.L. Schwartz and R.S. Nussenzweig, Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies, J Immunol 132(2) (1984), 909-913.
24. B.J. Sina, C. Wright, R. Ballou and M. Hollingdale, A protective monoclonal antibody with dual specificity for Plasmodium falciparum and Plasmodium berghei circumsporozoite proteins, Exp Parasitol 74(4) (1992), 431-440.
25. E.H. Nardin, V. Nussenzweig, R.S. Nussenzweig, W.E. Collins, K.T. Harinasuta, P. Tapchaisri and Y. Chomcharn, Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax, J Exp Med 156(1) (1982), 20-30.
26. J. McCafferty, A.D. Griffiths, G. Winter and D.J. Chiswell, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348(6301) (1990), 552-554.
27. E.H. Nardin, R.S. Nussenzweig, I.A. McGregor and J.H. Bryan, Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria, Science 206(4418) (1979), 597-599.
28. I.A. McGregor, Studies in the Acquisition of Immunity of Plasmodium Falciparum Infections in Africa, Trans R Soc Trop Med Hyg 58 (1964), 80-92.
29. A.V. Hill, C.E. Allsopp, D. Kwiatkowski, N.M. Anstey, P. Twumasi, P.A. Rowe, S. Bennett, D. Brewster, A.J. McMichael and B.M. Greenwood, Common west African HLA antigens are associated with protection from severe malaria, Nature 352(6336) (1991), 595-600.
30. K.N. Potter, Y. Li and J.D. Capra, Antibody production in the baculovirus expression system, Int Rev Immunol 10(2-3) (1993), 103-112.